What is going on with the children of Fukushima?

Mass thyroid screenings of children at risk of cancer from the 2011 meltdown at Fukushima handed Japanese health officials what they most feared finding—lots of abnormalities. And now the program has set off a firestorm of fear and criticism.

Do the positive findings have anything to do with what happened at the nuclear power plant? Or did the abnormalities originate well before the disaster?

Either way, are the aggressive screenings leading to appropriate care protocols—or just causing undue anxiety?

Science doesn’t have all the answers, but it knows what questions to ask: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.